Cardinal Health, Inc.
CAH NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 11, 2026
ET
EPS Est.
2.42
EPS Actual
2.91
Revenue Est.
$65.15B
Revenue Actual
$63.67B
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2027 Q1
EPS Est.
2.91
Revenue Est.
$66.71B
Company Overview
Cardinal Health, Inc. (ticker CAH) is listed on NYSE with a market cap of about $53.75B. Its next earnings report (FY2027 Q1) is expected on Oct 29, 2026 (ET), Pre-market, with consensus EPS of 2.91. In the last 15 reported quarters, EPS beat consensus estimates 15 times.
Actual EPS TrendRecently15Term · Feb 2, 2023 → Aug 11, 2026
Feb 2, 2023Range: 1.32 ~ 3.17Aug 11, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 11, 2026 | -- | 2.42 | Above forecast↑2.91 | $65.15B | $63.67B |
| Apr 30, 2026 | -- | 2.79 | 3.17 | $62.1B | $60.94B |
| Feb 5, 2026 | -- | 2.34 | 2.63 | $65.08B | $65.63B |
| Oct 30, 2025 | -- | 2.18 | Above forecast↑2.55 | $59.24B | $64.01B |
| Aug 12, 2025 | -- | 2.04 | 2.08 | $60.89B | $60.16B |
| May 1, 2025 | -- | 2.17 | 2.35 | $55.39B | $54.88B |
| Jan 30, 2025 | -- | 1.74 | 1.93 | $55.02B | $55.26B |
| Nov 1, 2024 | -- | 1.62 | Above forecast↑1.88 | $50.9B | $52.28B |
| Aug 14, 2024 | -- | 1.73 | 1.84 | $58.64B | $59.87B |
| May 2, 2024 | -- | 1.95 | 2.08 | $56.05B | $54.91B |
| Feb 1, 2024 | -- | 1.60 | 1.82 | $57.01B | $57.45B |
| Nov 3, 2023 | -- | 1.40 | Above forecast↑1.73 | $54.76B | $54.76B |
| Aug 15, 2023 | -- | 1.48 | 1.55 | $52.72B | $53.45B |
| May 4, 2023 | -- | 1.49 | Above forecast↑1.74 | $49.71B | $50.49B |
| Feb 2, 2023 | -- | 1.13 | Above forecast↑1.32 | $50.72B | $51.47B |
Original Filings (SEC)
10-K2026-08-11 ↗
8-K2026-08-11 ↗
8-K2026-08-11 ↗
8-K2026-08-05 ↗
10-Q2026-04-30 ↗
8-K2026-04-30 ↗
8-K2026-03-23 ↗
8-K2026-03-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
